Investor mix
9 investors on record; lead investors include Pontifax.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 44% |
| Private equity | 1 | 11% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 3 | 33% |
Early stage biopharma developing precision drugs for MDR bacterial infections
9 investors on record; lead investors include Pontifax.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 44% |
| Private equity | 1 | 11% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 3 | 33% |